Your position:m.limatoxi.com >> EN >> Pharmaceutical News >> Company >> Simcere completes Endostar phase IV study >> article
 
Simcere completes Endostar phase IV study
Editor:lizz    Clicks:0    Date:2010-3-29 9:11:46
Keyword: Simcere
Healthoo Information:
The study was the first phase-IV clinical study for a Class-1 new drug in China. This is the largest clinical study ever conducted in China.
 
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
  Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
  • Merck and Simcere launch JV in China
  • Simcere collaborates with BMS to develop ...
  • Simcere RA medication gets approval
  • Merck and Simcere signed agreement to es...
  • Celgen gets new drug approval for Qiangk...
  • Simcere obtains right of BMS-817378 in C...
  • Simcere and BMS partner to develop oncol...
  • Simcere acquires additional satke in Boda
  • Simcere Pharma make response to vaccines ...
  • Simcere acquires production approval for Rosu...
  • Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map